Specialty Pharmacy

Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.

Genetically determined telomere length may not influence mortality.

Combination of recombinant factor VIII with a fusion protein allows for less frequent treatment.

Diets with more animal protein and less soluble fiber increases cancer risk.

Researchers find significant reduction in lung cancer-specific deaths.

Teva is voluntarily recalling select lots of intravenous fluorouracil (Adrucil).

Patients with AIDS face a 4-fold greater risk of age-related macular degeneration (AMD) than their HIV-uninfected counterparts.

Cancer rates significantly greater compared with non-infected individuals.

Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses the elements of an optimal program for monitoring patients with multiple sclerosis to ensure adherence.

Boosting immune system improves efficacy of antiretroviral drugs.

Americans are feeling more responsible for their health, with 64% indicating in a national survey that they could be making more decisions about their health and wellness.

A look back at the top stories of the week on Specialty Pharmacy Times from April 27 to May 1.

Sandoz has introduced its ready-to-use levoleucovorin injection to the US market.

Blocking production of specific immune cell protects against onset of MS.

Therapy shows promise in treatment of hepatitis C genotype-1 mono-infected patients.

When counseling patients on infertility treatment, health care providers need to perform the roles of patient advocates, researchers, educators, and confidantes, among others.

Highest uninsured rates found in patients with testicular, stomach, and cervical cancers.

Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.

The FDA today approved the first spray-dried fibrin sealant to be used to control bleeding during surgery.

Isavuconazonium sulfate (Cresemba) is now available to treat 2 rare yet life-threatening fungal infections.

Two new drugs showed significant reversal of disease severity.

BRAF mutations commonly found in melanoma also seen in subset of lung cancer patients.

Pharmacists can expect to answer patient questions related to HIV more often in the beginning of the week.

Merck's once-daily treatment regimen of grazoprevir and elbasvir may bring added competition to HCV drug market.

Introduction of protein to pancreatic cancer cells causes them to revert back to normal.

Gene may help identify clue to separation of overactive and underactive immune activity.

Partnership will inform and educate industry stakeholders and policymakers about the unique demands specialty medicines place on pharmacies pharmacists and patients.

Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses the changing role of specialty pharmacy in cancer treatment.

Nearly 30% of total biologic drug costs paid out-of-pocket.

Taking over-the-counter supplements beyond the recommended amount could increase cancer risk.